doi: 10.1016/j.mito.2013.01.008 15
Operational Impacts Care Management Programs: Plans must scale care management programs to handle up to 30% more members receiving GLP-1 prescriptions, requiring investment in digital tools and personnel
Published Phase 2 data (NEJM, 2023) showed retatrutide achieving up to 24.2% body weight reduction over 48 weeks and significant hepatic fat reduction, supporting research into obesity, NAFLD/MASH, and insulin resistance models
This hormone plays a major role in controlling appetite, regulating blood sugar, slowing gastric emptying, and signaling the brain that youre satisfied
Weight-bearing becomes more comfortable
This ensures weight has stabilized and allows for better long-term results